Focuses on clinical features, laboratory diagnosis, prognostic factors and therapeutic
management of patients with acquired hemophilia. Association of acquired hemophilia with …

The inhibition of factor VIII by autoantibody development, or acquired hemophilia, occurs in
approximately one person per million each year and can cause life-threatening bleeding …

Acquired hemophilia A (AHA) is an autoimmune disease caused by an autoantibody to
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …

Abstract Background Acquired hemophilia A (AHA) is a rare bleeding disorder caused by an
autoantibody to coagulation factor (F) VIII. It is characterized by soft tissue bleeding in …

Acquired haemophilia is a rare but life-threatening acquired bleeding diathesis caused by
autoimmune depletion of factor VIII. This occurs most frequently in elderly patients who lack …

Effective treatment is required to stop bleeding which may be relentless and life-threatening,
The most effective therapy is usually one that will produce a rise in the plasma factor VIII to a …

BACKGROUND: Acquired hemophilia is a rare disease caused by the development of auto-
antibodies against factor VIII. SUBJECTS AND METHODS: We studied the characteristics …

Acquired haemophilia is a potentially life‐threatening bleeding disorder caused by the
development of autoantibodies against coagulation factors, most commonly against factor …

Acquired haemophilia A is an auto‐immune disease caused by an inhibitory antibody to
factor VIII. Patients with an acquired factor VIII inhibitor are at risk of life‐and limb …

Hemophilia A is an X-linked hereditary bleeding disorder due to the deficiency of
coagulation factor VIII (FVIII). According to the degree of FVIII deficiency, mild, moderate or …